{
    "clinical_study": {
        "@rank": "146155", 
        "acronym": "SPI COHERENCE", 
        "arm_group": [
            {
                "arm_group_label": "SPI Medical device", 
                "arm_group_type": "Experimental", 
                "description": "SPI medical device used during PET/CT 4D imaging in a synchronized mode centered on the thorax."
            }, 
            {
                "arm_group_label": "reference medical device : RPM", 
                "arm_group_type": "Active Comparator", 
                "description": "Reference medical device (RPM) used simultaneously during PET/CT 4D imaging in a synchronized mode centered on the thorax."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a pilot study, single-center, prospective, open-label, to assess the acceptability\n      and performance of the experimental medical device (SPI) used during an imaging examination\n      (PET / CT 4D imaging in synchronized mode centered on the thorax). Each patient will be its\n      own control, since the imaging examination will be synchronized simultaneously with the two\n      systems: tested Medical Device (SPI) and reference Medical Device(RPM)."
        }, 
        "brief_title": "Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Non Small Cell Lung Cancer", 
            "Lung Nodule"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patient for whom there is an indication of PET/CT 18FDG imaging for thoracic oncology\n             ; this indication is consistent with the Standard Options Recommendations or was\n             validated during Multidisciplinary Consultation Meeting :\n\n               -  Either an extension assessment of non-small cell lung cancer;\n\n               -  Either the characterization of single  pulmonary nodule; Or - the definition of\n                  the target volume in radiotherapy.\n\n          2. Patient who meets the following criteria to be eligible for an PET/CT imaging:\n\n               -  Patient able to maintain a supine position for 60 minutes\n\n               -  Patient with no bronchopulmonary infection and with no upper aero digestive\n                  tract acute infection in progress  (increased risk of false positives)\n\n          3. Age \u2265 18 years\n\n          4. WHO \u2264 1\n\n          5. Well-informed written consent signed by the patient and collected before any specific\n             procedure in the study\n\n          6. Patient member in a national insurance scheme\n\n        Exclusion Criteria:\n\n          1. Patient with a bronchial carcinoid or bronchoalveolar cancer\n\n          2. Patient with acute bronchopneumopathy\n\n          3. Not stabilized diabetic patient\n\n          4. Patient with an absolute indication against spirometry: ongoing pneumothorax or\n             within the previous month, pleural biopsy or puncture within the previous month,\n             hemoptysis, severe asthma, tuberculosis\n\n          5. Any usual relative indication against spirometry: ongoing bronchial infections,\n             acute asthma, decompensation of chronic respiratory failure, respiratory pain\n\n          6. Any usual formal indication against imaging  examination PET/CT (important\n             claustrophobia)\n\n          7. Patient unable to follow study procedures\n\n          8. Pregnant women or nursing mothers can not participate in the study\n\n          9. Men and women of childbearing age must use effective contraception at study entry and\n             throughout the study\n\n         10. Any other medical conditions making the inclusion of the patient in the study\n             inappropriate in the opinion of the investigator\n\n         11. Patient under legal guardianship"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01720186", 
            "org_study_id": "12POUM01"
        }, 
        "intervention": {
            "arm_group_label": [
                "SPI Medical device", 
                "reference medical device : RPM"
            ], 
            "intervention_name": "PET/CT 4D imaging in a synchronized mode centered on the thorax.", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lung Cancer", 
            "PET/CT", 
            "FDG", 
            "Respiratory synchronization"
        ], 
        "lastchanged_date": "May 29, 2013", 
        "location": {
            "contact": {
                "email": "courbon.frederic@claudiusregaud.fr", 
                "last_name": "Frederic COURBON, PhD", 
                "phone": "+33 5.67.69.63.20"
            }, 
            "facility": {
                "address": {
                    "city": "Toulouse", 
                    "country": "France", 
                    "zip": "31052"
                }, 
                "name": "Institut Claudius REGAUD"
            }, 
            "investigator": [
                {
                    "last_name": "Frederic COURBON, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Slimane ZERDOUD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lawrence DIERICKX, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer", 
        "overall_contact": {
            "email": "courbon.frederic@claudiusregaud.fr", 
            "last_name": "Frederic MD COURBON, PhD", 
            "phone": "+33 5.67.69.63.20"
        }, 
        "overall_official": {
            "affiliation": "Institut Claudius Regaud", 
            "last_name": "Frederic COURBON, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "feasibility is evaluated in a composite end point (success will be obtained in case of concomitant success of the 4 sub-criteria assessment):\nTolerance / acceptability of the patient to breathe into SPI throughout the examination)\nDetection of breath cycle of the patient by measuring dCycleSpi (dCycleSpi = Number of synchronization signals emitted by SPI / total number of breath cycle * 100).\nAccuracy of detection of inspiratory peak amplitudes with SPI medical device: by measuring dtSpi (dtSpi = standard deviation of the time lag between synchronization signals and maximum inspiratory amplitude for each cycle).\nProduction of images with a correct segmentation of BTV during PET/CT synchronized exam with SPI device\"", 
            "measure": "Feasibility of the PET/CT synchronized exam with SPI device (\"success\" or \"failure\" )", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01720186"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Measure of dCycleRpm (dCycleRpmi = Number of synchronization signals emitted by RPM / total number of breath cycle * 100)", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "dtRpm = standard deviation of the time lag between synchronization signals and maximum inspiratory amplitude for each cycle", 
                "measure": "Accuracy of detection of maximum inspiratory amplitudes with RPM medical device:  evaluated by measuring dtRpm", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Measure of BTVrpm (= biologic tumoral volume)", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Institut Claudius Regaud", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut Claudius Regaud", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}